FDA’s regulatory policy not biased against Indian drug makers

July 17, 2014

Amid news of regulatory action taken by the U.S. watchdog against pharmaceutical companies, at first glance it would appear that mostly Indian companies have come under fire.

Amid news of regulatory action taken by the U.S. watchdog against pharmaceutical companies, at first glance it would appear that mostly Indian companies have come under fire. But in fact, as the U.S. Food and Drug Administration sets the quality bar higher, warning letters have reached drug makers in the European Union, Australia, China and Canada, as well as many companies in the United States.

This focus on overseas drug manufacturers is not surprising. The United States imports about 40 percent of all finished drugs sold on its market and approximately 80 percent of the active ingredients involved in its own pharmaceutical production. Bearing in mind the fact that imports keep rising, both in terms of volume and value, it is understandable that the FDA remains watchful about the quality of products reaching U.S. consumers, according to the Pharma Letter.

Still, data regarding FDA warning letters over the past five years shows that 114 U.S.-based producers have been reprimanded by the regulator for marketing offences or manufacturing failings, compared to 22 Indian companies over the same period.

According to a recent report from rating agency Crisil, the high number of examples of enforcement action against Indian manufacturers is not a demonstration of anti-Indian bias, but a reflection of the fact that India has the highest number of Abbreviated New Drug Application approvals. Sudip Sural, senior director at Crisil Ratings, said that in terms of generic drug supply, India comes second only to Canada when it comes to imports in the United States.

Sponsored Recommendations

Choosing The Right Partner for CHIPS Act Investments

As the U.S. looks to invest in the semiconductor research and production using CHIPS Act 2022 funding, it's important to choose the right partner.

EMWD Uses Technology to Meet Sustainability Goals

Eastern Municipal Water District pilots artificial intelligence-enabled control and machine learning to help save energy, reduce costs, and improve quality.

Protein Processing Solutions: Automation & Control

For protein processors looking to address industry challenges, improve efficiency, and stay ahead in a competitive market, Rockwell Automation offers tailored automation, control...

Automotive Manufacturing Innovation: Smart Solutions for a Connected Future

Rockwell Automation provides automation and control systems tailored for the automotive and tire industries, supporting electric vehicle production, tire production, battery production...